Alpha Tau Medical cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 23 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||
| Net Income | 4.81M | 3.81M | -25.74M | 53.49M | 2.60M | 3.39M | 8.14M | 8.64M | 4.99M | 7.35M | 7.98M | 7.36M | 6.92M | 9.47M | 8.49M | 9.98M | 11.70M | 12.21M | 22.96M | 45.35M | |||
| Share-based CompensationStock Comp. | 5.33M | 1.98M | 1.46M | 8.24M | 19.51M | 10.52M | 16.28M | 0.86M | 15.44M | 9.35M | 13.95M | ||||||||||||
| Cash from OperationsCash from Ops. | -6.58M | -8.74M | |||||||||||||||||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.23M | 0.24M | |||||||||||||||||||||
| Change in Working Capital | |||||||||||||||||||||||
| Change in Account PayablesChange Payables | 2.63M | -2.63M | |||||||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | -0.98M | -0.90M | |||||||||||||||||||||
| Change in TaxesChange Taxes | |||||||||||||||||||||||
| Investing Activities | |||||||||||||||||||||||
| Capital ExpendituresCapex | -0.30M | -0.38M | |||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.30M | -92.38M | |||||||||||||||||||||
| Financing Activities | |||||||||||||||||||||||
| Other financing activitiesOther financing | 1.35M | 1.91M | |||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 81.98M | 14.81M | |||||||||||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 1.32M | 2.02M | 3.52M | 4.17M | 2.71M | ||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 8.74M | ||||||||||||||||||||||
| Additional items | |||||||||||||||||||||||
| Exchange Rate EffectFX Effect | -0.05M | -0.24M | |||||||||||||||||||||
| Change in Cash | 75.05M | -86.55M | |||||||||||||||||||||
| Beginning Cash Balance | 12.66M | 13.72M | 12.20M | ||||||||||||||||||||
| Free Cash FlowFCF | -6.29M | -8.37M | |||||||||||||||||||||
| Net Cash FlowNCF | 75.10M | -86.31M |